Cellectar Biosciences

CLRB • NASDAQ • Stock Fundamentals

Cellectar Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James V. Caruso, with a market cap of $24.8M.

Market Cap$24.8M

Employees20.0

CEOJames V. Caruso

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Cellectar Biosciences

Cellectar Biosciences (CLRB) has a market capitalization of $24.8M and trades on NASDAQ.

Cellectar Biosciences has approximately 20 employees.